J M Pipas

Summary

Affiliation: Dartmouth-Hitchcock Medical Center
Country: USA

Publications

  1. ncbi A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma
    J Marc Pipas
    Neuro Oncology Program, Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center, 1 Medical Center Drive, New Hampshire, Lebanon, NH 03756, USA
    J Neurooncol 71:301-5. 2005
  2. ncbi Docetaxel/Gemcitabine followed by gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinoma
    J Marc Pipas
    Gastrointestinal Oncology Program, Dartmouth Hitchcock Medical Center Norris Cotton Cancer Center, One Medical Center Drive, Lebanon, NH 03756, USA
    Ann Surg Oncol 12:995-1004. 2005
  3. ncbi Effect of neoadjuvant therapy on local recurrence after resection of pancreatic adenocarcinoma
    Sarah E Greer
    Department of Surgery, Dartmouth Hitchcock Medical Center and Norris Cotton Cancer Center, Lebanon, NH 03756, USA
    J Am Coll Surg 206:451-7. 2008
  4. ncbi Phase I study of twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreas
    J M Pipas
    Dartmouth Hitchcock Medical Center Norris Cotton Cancer Center, Lebanon, NH 03756, USA
    Int J Radiat Oncol Biol Phys 50:1317-22. 2001
  5. ncbi A phase II study of thalidomide and irinotecan for treatment of glioblastoma multiforme
    Camilo E Fadul
    Department of Medicine, Section of Hematology Oncology, Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center Drive, One Medical Center Drive, Lebanon, NH 03756, USA
    J Neurooncol 90:229-35. 2008
  6. ncbi Endovascular recanalization of symptomatic portomesenteric venous obstruction after pancreaticoduodenectomy and radiation
    Eric K Hoffer
    Section of Vascular and Interventional Radiology, Dartmouth Hitchcock Medical Center and Norris Cotton Cancer Center, One Medical Center Drive, Lebanon, NH 03756, USA
    J Vasc Interv Radiol 20:1633-7. 2009
  7. ncbi A dose escalation trial of biweekly docetaxel and gemcitabine with filgrastim or pegfilgrastim for the treatment of patients with advanced solid tumors
    Konstantin H Dragnev
    Section of Hematology Oncology, Department of Medicine, Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, USA dragnev dartmouth edu
    Chemotherapy 56:135-41. 2010
  8. ncbi Atypical teratoid/rhabdoid tumor of the spine in an adult: case report and review of the literature
    Elena L Zarovnaya
    Department of Pathology, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, USA
    J Neurooncol 84:49-55. 2007
  9. ncbi Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines
    John P Mongan
    Department of Internal Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA
    Clin Colorectal Cancer 8:100-5. 2009
  10. ncbi A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer
    Robert S Sandler
    Department of Medicine, University of North Carolina, Chapel Hill 27599 7555, USA
    N Engl J Med 348:883-90. 2003

Collaborators

Detail Information

Publications11

  1. ncbi A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma
    J Marc Pipas
    Neuro Oncology Program, Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center, 1 Medical Center Drive, New Hampshire, Lebanon, NH 03756, USA
    J Neurooncol 71:301-5. 2005
    ..We conducted a Phase II trial of these agents in combination with filgrastim (G-CSF) in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma...
  2. ncbi Docetaxel/Gemcitabine followed by gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinoma
    J Marc Pipas
    Gastrointestinal Oncology Program, Dartmouth Hitchcock Medical Center Norris Cotton Cancer Center, One Medical Center Drive, Lebanon, NH 03756, USA
    Ann Surg Oncol 12:995-1004. 2005
    ..We conducted a phase II trial of dose-intense docetaxel and gemcitabine followed by twice-weekly gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinoma...
  3. ncbi Effect of neoadjuvant therapy on local recurrence after resection of pancreatic adenocarcinoma
    Sarah E Greer
    Department of Surgery, Dartmouth Hitchcock Medical Center and Norris Cotton Cancer Center, Lebanon, NH 03756, USA
    J Am Coll Surg 206:451-7. 2008
    ..It is unknown whether neoadjuvant chemoradiotherapy, compared with adjuvant chemoradiotherapy, decreases the rate of local recurrence after resection of pancreatic adenocarcinoma...
  4. ncbi Phase I study of twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreas
    J M Pipas
    Dartmouth Hitchcock Medical Center Norris Cotton Cancer Center, Lebanon, NH 03756, USA
    Int J Radiat Oncol Biol Phys 50:1317-22. 2001
    ..To determine the maximum tolerated dose and dose-limiting toxicity associated with twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreas...
  5. ncbi A phase II study of thalidomide and irinotecan for treatment of glioblastoma multiforme
    Camilo E Fadul
    Department of Medicine, Section of Hematology Oncology, Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center Drive, One Medical Center Drive, Lebanon, NH 03756, USA
    J Neurooncol 90:229-35. 2008
    ..To evaluate the combination of thalidomide and irinotecan, we conducted a phase II trial in adults with newly-diagnosed or recurrent GBM...
  6. ncbi Endovascular recanalization of symptomatic portomesenteric venous obstruction after pancreaticoduodenectomy and radiation
    Eric K Hoffer
    Section of Vascular and Interventional Radiology, Dartmouth Hitchcock Medical Center and Norris Cotton Cancer Center, One Medical Center Drive, Lebanon, NH 03756, USA
    J Vasc Interv Radiol 20:1633-7. 2009
    ..One patient showed no improvement clinically. Recurrent ascites after stent occlusion was successfully treated in two patients. Percutaneous transhepatic recanalization appears to be a safe and effective therapy in this population...
  7. ncbi A dose escalation trial of biweekly docetaxel and gemcitabine with filgrastim or pegfilgrastim for the treatment of patients with advanced solid tumors
    Konstantin H Dragnev
    Section of Hematology Oncology, Department of Medicine, Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, USA dragnev dartmouth edu
    Chemotherapy 56:135-41. 2010
    ..A single-institution phase I trial to determine the feasibility of using filgrastim or pegfilgrastim to increase the dose intensity of biweekly docetaxel and gemcitabine...
  8. ncbi Atypical teratoid/rhabdoid tumor of the spine in an adult: case report and review of the literature
    Elena L Zarovnaya
    Department of Pathology, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, USA
    J Neurooncol 84:49-55. 2007
    ..An unrestricted autopsy was performed. To our knowledge, this is the first case of a spinal atypical teratoid/rhabdoid tumor in an adult fully documented with molecular, immunohistochemical, cytogenetic and autopsy findings...
  9. ncbi Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines
    John P Mongan
    Department of Internal Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA
    Clin Colorectal Cancer 8:100-5. 2009
    ....
  10. ncbi A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer
    Robert S Sandler
    Department of Medicine, University of North Carolina, Chapel Hill 27599 7555, USA
    N Engl J Med 348:883-90. 2003
    ..Experimental studies in animals and observational studies in humans suggest that regular aspirin use may decrease the risk of colorectal adenomas, the precursors to most colorectal cancers...
  11. ncbi Bortezomib with or without irinotecan in relapsed or refractory colorectal cancer: results from a randomized phase II study
    Peter S Kozuch
    Continuum Cancer Centers of New York, St Luke s Roosevelt Hospital, New York, NY, USA
    J Clin Oncol 26:2320-6. 2008
    ..To evaluate the efficacy and toxicity of bortezomib with or without irinotecan, in patients with relapsed or refractory colorectal cancer (CRC)...